RecruitingNCT06377462

Multicenter, Interdisciplinary National VEXAS Registry With Accompanying Biomaterial Collection

Sponsor

Technische Universität Dresden

Enrollment

500 participants

Start Date

Mar 13, 2024

Study Type

OBSERVATIONAL

Conditions

VEXAS Syndrome

Summary

The aim is rapid collection of real-life data on the epidemiology, treatment and disease course in patients with VEXAS syndrome during routine clinical practice and collect biomaterials to evaluate genotype-phenotype associations, determine optimal treatment schedule, identify diagnostic features and biomarkers

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with vexas syndrome. The study is currently recruiting participants at 17 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(17)

Universitätsklinikum Aachen

Aachen, Germany

Klinikum Chemnitz gGmbH

Chemnitz, Germany

Universitätsklinikum Carl Gustav Carus

Dresden, Germany

Universitätsklinikum Düsseldorf

Düsseldorf, Germany

Evang. Kliniken Essen-Mitte

Essen, Germany

Universitätsmedizin Göttingen

Göttingen, Germany

Universitätsklinikum Hamburg-Eppendorf

Hamburg, Germany

Universitätsklinikum Jena

Jena, Germany

Universitätsklinikum Leipzig AöR

Leipzig, Germany

Universitätsmedizin Mannheim

Mannheim, Germany

Klinikum rechts der Isar TUM

München, Germany

Klinikum Nürnberg, Campus Nord

Nuremberg, Germany

Klinikum Osnabrück GmbH

Osnabrück, Germany

Helios Kliniken Schwerin GmbH

Schwerin, Germany

Robert Bosch Gesellschaft für Medizinische Forschung mb

Stuttgart, Germany

Krankenhaus der Barmherzigen Brüder

Trier, Germany

Universitätsklinikum Tübingen

Tübingen, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06377462

Related Trials

Pacritinib in Vacuoles, E1 Ubiqutin-activating Enzyme, X-linked, Autoinflammatory, Somatic (VEXAS) Syndrome

NCT065381811 location

A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS)

NCT0678237339 locations

AutoInflammatory Disease Alliance Registry (AIDA)

NCT05200715112 locations

Aplastic Anaemia and Other Bone Marrow Failure Syndromes Registry (AAR)

ACTRN1262300046169535 locations